Share Price and Basic Stock Data
Last Updated: February 3, 2026, 1:55 am
| PEG Ratio | 79.40 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Astral Ltd, operating in the plastics pipes and fittings industry, reported a market capitalization of ₹38,942 Cr and a current price of ₹1,450 per share. The company has demonstrated a robust revenue trajectory, with sales rising from ₹1,057 Cr in FY 2014 to ₹5,158 Cr in FY 2023. This growth trajectory continued into FY 2024, with sales recorded at ₹5,641 Cr, and a trailing twelve months (TTM) revenue of ₹6,017 Cr. Quarterly sales figures also reflect a steady upward trend, with ₹1,172 Cr in September 2022 and reaching ₹1,681 Cr by March 2025. The company’s ability to maintain this growth amidst fluctuating market conditions underlines its strong market position. In terms of profitability, operating profit margins stood at 16% and have remained relatively stable, reinforcing the company’s operational efficiency.
Profitability and Efficiency Metrics
Astral Ltd’s profitability metrics reveal a mixed performance over recent periods. The net profit for FY 2023 was reported at ₹472 Cr, which increased to ₹546 Cr in FY 2024, before declining to ₹519 Cr in FY 2025. The operating profit margin (OPM) remained consistent around 16% for FY 2024 and FY 2025, which is commendable in the context of industry norms. The return on equity (ROE) stood at 14.9%, while the return on capital employed (ROCE) was recorded at 19.7%, indicating efficient capital utilization. The interest coverage ratio (ICR) of 23.90x suggests that the company comfortably meets its interest obligations, reflecting a strong financial position. However, the net profit margin saw a decline to 8.89% in FY 2025 compared to 9.67% in FY 2024, indicating potential cost pressures that need to be monitored closely.
Balance Sheet Strength and Financial Ratios
Astral Ltd’s balance sheet exhibits solid stability, with total assets reported at ₹5,048 Cr and total liabilities at ₹5,048 Cr for FY 2025. The company’s reserves have grown to ₹3,590 Cr, providing a strong buffer for future investments and operational needs. Borrowings stood at ₹233 Cr, resulting in a low debt-to-equity ratio of 0.03, indicating a conservative financial structure. The current ratio of 1.88x suggests that Astral possesses sufficient liquidity to cover its short-term liabilities, while the quick ratio of 0.99x indicates a slight reliance on inventory for liquidity. Furthermore, the price-to-book value (P/BV) ratio is at 9.62x, which is relatively high compared to the sector, suggesting that the market has high expectations for the company’s growth potential. However, this also indicates a risk of overvaluation, particularly if future growth does not meet these expectations.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Astral Ltd reflects a stable ownership structure, with promoters holding 54.21% of the company as of September 2025. The foreign institutional investors (FIIs) have a significant stake of 16.61%, while domestic institutional investors (DIIs) hold 17.49%. This distribution indicates strong institutional confidence in the company’s prospects. The number of shareholders stood at 2,97,582, indicating a broad base of retail investors. However, the gradual decrease in promoter shareholding from 55.85% in December 2022 to 54.21% in September 2025 could raise concerns about long-term commitment. The public shareholding has remained relatively stable, suggesting that retail confidence in the company remains intact. Overall, the diverse shareholding structure enhances governance and reflects investor confidence in Astral’s operational strategy.
Outlook, Risks, and Final Insight
The outlook for Astral Ltd remains cautiously optimistic, bolstered by its strong market position and solid financial metrics. The company’s ability to sustain revenue growth and maintain profitability amidst economic fluctuations is commendable. However, potential risks include rising raw material costs, which could pressure margins, and the high valuation indicated by the P/BV ratio. Furthermore, any significant changes in regulatory frameworks governing the plastics industry could impact operations. The company must navigate these challenges effectively to uphold its growth trajectory. If Astral can leverage its strong brand and operational efficiencies, it may continue to thrive in the competitive landscape. Conversely, failure to manage costs or adapt to market changes could hinder its performance, necessitating a strategic reassessment to safeguard shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Dutron Polymers Ltd | 61.0 Cr. | 102 | 175/101 | 23.7 | 49.1 | 1.48 % | 12.3 % | 9.68 % | 10.0 |
| Captain Polyplast Ltd | 395 Cr. | 65.6 | 109/58.4 | 20.0 | 28.0 | 0.00 % | 16.1 % | 15.0 % | 2.00 |
| Captain Pipes Ltd | 147 Cr. | 9.58 | 18.5/9.11 | 41.4 | 2.69 | 0.00 % | 17.0 % | 13.5 % | 1.00 |
| Caprihans India Ltd | 122 Cr. | 83.7 | 169/78.1 | 269 | 0.00 % | 0.78 % | 18.9 % | 10.0 | |
| Ashish Polyplast Ltd | 11.2 Cr. | 33.0 | 51.0/28.0 | 160 | 20.7 | 0.00 % | 5.09 % | 2.58 % | 10.0 |
| Industry Average | 5,565.13 Cr | 194.50 | 56.93 | 87.36 | 0.26% | 10.40% | 10.62% | 8.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,172 | 1,268 | 1,506 | 1,283 | 1,363 | 1,370 | 1,625 | 1,384 | 1,370 | 1,397 | 1,681 | 1,361 | 1,577 |
| Expenses | 1,028 | 1,081 | 1,199 | 1,082 | 1,143 | 1,165 | 1,334 | 1,169 | 1,160 | 1,178 | 1,380 | 1,176 | 1,321 |
| Operating Profit | 144 | 186 | 307 | 202 | 220 | 205 | 291 | 214 | 210 | 219 | 302 | 185 | 257 |
| OPM % | 12% | 15% | 20% | 16% | 16% | 15% | 18% | 16% | 15% | 16% | 18% | 14% | 16% |
| Other Income | 14 | -2 | 12 | 12 | 13 | 6 | 10 | 12 | 9 | 12 | 9 | 9 | 11 |
| Interest | 14 | 9 | 3 | 6 | 8 | 8 | 8 | 8 | 10 | 14 | 10 | 12 | 16 |
| Depreciation | 45 | 46 | 44 | 46 | 49 | 50 | 52 | 56 | 60 | 63 | 65 | 72 | 72 |
| Profit before tax | 99 | 130 | 272 | 162 | 177 | 154 | 241 | 163 | 149 | 154 | 236 | 110 | 180 |
| Tax % | 24% | 27% | 24% | 26% | 26% | 26% | 25% | 27% | 27% | 27% | 25% | 28% | 25% |
| Net Profit | 75 | 95 | 206 | 119 | 132 | 113 | 181 | 120 | 109 | 113 | 178 | 79 | 135 |
| EPS in Rs | 2.57 | 3.46 | 7.66 | 4.46 | 4.88 | 4.23 | 6.76 | 4.48 | 4.09 | 4.25 | 6.67 | 3.02 | 5.02 |
Last Updated: January 13, 2026, 1:21 am
Below is a detailed analysis of the quarterly data for Astral Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1,577.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,361.00 Cr. (Jun 2025) to 1,577.00 Cr., marking an increase of 216.00 Cr..
- For Expenses, as of Sep 2025, the value is 1,321.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,176.00 Cr. (Jun 2025) to 1,321.00 Cr., marking an increase of 145.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 257.00 Cr.. The value appears strong and on an upward trend. It has increased from 185.00 Cr. (Jun 2025) to 257.00 Cr., marking an increase of 72.00 Cr..
- For OPM %, as of Sep 2025, the value is 16.00%. The value appears strong and on an upward trend. It has increased from 14.00% (Jun 2025) to 16.00%, marking an increase of 2.00%.
- For Other Income, as of Sep 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Jun 2025) to 11.00 Cr., marking an increase of 2.00 Cr..
- For Interest, as of Sep 2025, the value is 16.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.00 Cr. (Jun 2025) to 16.00 Cr., marking an increase of 4.00 Cr..
- For Depreciation, as of Sep 2025, the value is 72.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 72.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 180.00 Cr.. The value appears strong and on an upward trend. It has increased from 110.00 Cr. (Jun 2025) to 180.00 Cr., marking an increase of 70.00 Cr..
- For Tax %, as of Sep 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Jun 2025) to 25.00%, marking a decrease of 3.00%.
- For Net Profit, as of Sep 2025, the value is 135.00 Cr.. The value appears strong and on an upward trend. It has increased from 79.00 Cr. (Jun 2025) to 135.00 Cr., marking an increase of 56.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 5.02. The value appears strong and on an upward trend. It has increased from 3.02 (Jun 2025) to 5.02, marking an increase of 2.00.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:37 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,057 | 1,410 | 1,678 | 1,895 | 2,073 | 2,507 | 2,578 | 3,176 | 4,394 | 5,158 | 5,641 | 5,832 | 6,017 |
| Expenses | 902 | 1,242 | 1,470 | 1,633 | 1,759 | 2,126 | 2,136 | 2,539 | 3,640 | 4,349 | 4,717 | 4,886 | 5,054 |
| Operating Profit | 155 | 168 | 208 | 261 | 314 | 382 | 442 | 638 | 754 | 810 | 925 | 946 | 963 |
| OPM % | 15% | 12% | 12% | 14% | 15% | 15% | 17% | 20% | 17% | 16% | 16% | 16% | 16% |
| Other Income | 2 | 3 | -4 | 8 | 13 | 15 | 11 | 25 | 35 | 37 | 36 | 41 | 41 |
| Interest | 31 | 25 | 30 | 18 | 22 | 32 | 39 | 13 | 13 | 40 | 29 | 41 | 52 |
| Depreciation | 22 | 36 | 42 | 50 | 57 | 81 | 108 | 116 | 127 | 178 | 198 | 243 | 272 |
| Profit before tax | 105 | 110 | 132 | 201 | 248 | 283 | 306 | 533 | 648 | 628 | 734 | 702 | 680 |
| Tax % | 24% | 29% | 22% | 28% | 29% | 30% | 18% | 23% | 24% | 25% | 26% | 26% | |
| Net Profit | 79 | 78 | 102 | 145 | 176 | 197 | 250 | 408 | 490 | 472 | 546 | 519 | 505 |
| EPS in Rs | 1.26 | 2.89 | 3.79 | 5.44 | 6.58 | 7.36 | 9.25 | 15.10 | 18.06 | 17.00 | 20.33 | 19.50 | 18.96 |
| Dividend Payout % | 5% | 6% | 5% | 5% | 4% | 4% | 6% | 10% | 12% | 21% | 18% | 19% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -1.27% | 30.77% | 42.16% | 21.38% | 11.93% | 26.90% | 63.20% | 20.10% | -3.67% | 15.68% | -4.95% |
| Change in YoY Net Profit Growth (%) | 0.00% | 32.04% | 11.39% | -20.78% | -9.45% | 14.97% | 36.30% | -43.10% | -23.77% | 19.35% | -20.62% |
Astral Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 18% |
| 3 Years: | 10% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 15% |
| 3 Years: | 2% |
| TTM: | -11% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 16% |
| 3 Years: | -6% |
| 1 Year: | -27% |
| Return on Equity | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 19% |
| 3 Years: | 17% |
| Last Year: | 15% |
Last Updated: September 4, 2025, 11:55 pm
Balance Sheet
Last Updated: December 4, 2025, 12:59 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 12 | 12 | 12 | 12 | 12 | 15 | 20 | 20 | 27 | 27 | 27 | 27 |
| Reserves | 304 | 607 | 696 | 835 | 1,006 | 1,266 | 1,488 | 1,876 | 2,316 | 2,684 | 3,161 | 3,590 | 3,749 |
| Borrowings | 142 | 203 | 197 | 229 | 189 | 275 | 191 | 80 | 98 | 87 | 119 | 233 | 256 |
| Other Liabilities | 237 | 344 | 397 | 386 | 468 | 546 | 595 | 697 | 952 | 1,564 | 1,188 | 1,198 | 1,166 |
| Total Liabilities | 694 | 1,165 | 1,301 | 1,462 | 1,675 | 2,099 | 2,289 | 2,673 | 3,387 | 4,362 | 4,496 | 5,048 | 5,198 |
| Fixed Assets | 289 | 557 | 645 | 741 | 842 | 1,105 | 1,255 | 1,314 | 1,496 | 1,950 | 2,299 | 2,712 | 2,773 |
| CWIP | 8 | 27 | 15 | 25 | 73 | 81 | 44 | 57 | 123 | 126 | 151 | 116 | 186 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
| Other Assets | 397 | 582 | 641 | 695 | 759 | 913 | 990 | 1,302 | 1,768 | 2,286 | 2,046 | 2,220 | 2,233 |
| Total Assets | 694 | 1,165 | 1,301 | 1,462 | 1,675 | 2,099 | 2,289 | 2,673 | 3,387 | 4,362 | 4,496 | 5,048 | 5,198 |
Below is a detailed analysis of the balance sheet data for Astral Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00 Cr..
- For Reserves, as of Sep 2025, the value is 3,749.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,590.00 Cr. (Mar 2025) to 3,749.00 Cr., marking an increase of 159.00 Cr..
- For Borrowings, as of Sep 2025, the value is 256.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 233.00 Cr. (Mar 2025) to 256.00 Cr., marking an increase of 23.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,166.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,198.00 Cr. (Mar 2025) to 1,166.00 Cr., marking a decrease of 32.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 5,198.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,048.00 Cr. (Mar 2025) to 5,198.00 Cr., marking an increase of 150.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 2,773.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,712.00 Cr. (Mar 2025) to 2,773.00 Cr., marking an increase of 61.00 Cr..
- For CWIP, as of Sep 2025, the value is 186.00 Cr.. The value appears strong and on an upward trend. It has increased from 116.00 Cr. (Mar 2025) to 186.00 Cr., marking an increase of 70.00 Cr..
- For Investments, as of Sep 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 6.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,233.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,220.00 Cr. (Mar 2025) to 2,233.00 Cr., marking an increase of 13.00 Cr..
- For Total Assets, as of Sep 2025, the value is 5,198.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,048.00 Cr. (Mar 2025) to 5,198.00 Cr., marking an increase of 150.00 Cr..
Notably, the Reserves (3,749.00 Cr.) exceed the Borrowings (256.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 13.00 | -35.00 | 11.00 | 32.00 | 125.00 | 107.00 | 251.00 | 558.00 | 656.00 | 723.00 | 806.00 | 713.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 50 | 60 | 49 | 65 | 54 | 49 | 32 | 32 | 22 | 25 | 24 | 27 |
| Inventory Days | 92 | 92 | 84 | 76 | 94 | 88 | 124 | 88 | 91 | 96 | 100 | 109 |
| Days Payable | 87 | 93 | 96 | 80 | 92 | 86 | 109 | 96 | 93 | 88 | 95 | 92 |
| Cash Conversion Cycle | 55 | 60 | 38 | 61 | 56 | 51 | 47 | 23 | 20 | 33 | 29 | 44 |
| Working Capital Days | 56 | 64 | 30 | 39 | 37 | 27 | 42 | 12 | 13 | 17 | 16 | 25 |
| ROCE % | 34% | 21% | 18% | 22% | 23% | 23% | 21% | 29% | 29% | 24% | 23% | 20% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Equity Hybrid Fund | 5,200,000 | 0.87 | 722.02 | 4,681,500 | 2026-01-26 03:33:33 | 11.08% |
| UTI Flexi Cap Fund | 3,218,975 | 1.79 | 446.95 | 3,237,000 | 2026-01-26 03:33:33 | -0.56% |
| Nippon India Growth Mid Cap Fund | 2,000,000 | 0.66 | 277.7 | N/A | N/A | N/A |
| UTI Mid Cap Fund | 1,133,232 | 1.32 | 157.35 | 1,048,904 | 2026-01-26 03:33:33 | 8.04% |
| PGIM India Midcap Fund | 976,625 | 1.2 | 135.6 | N/A | N/A | N/A |
| UTI Large Cap Fund | 923,716 | 0.96 | 128.26 | 892,553 | 2025-12-15 02:34:47 | 3.49% |
| Aditya Birla Sun Life Large and Mid Cap Fund | 847,991 | 2.04 | 117.74 | 809,839 | 2025-12-15 08:18:28 | 4.71% |
| Franklin India Mid Cap Fund | 775,000 | 0.84 | 107.61 | N/A | N/A | N/A |
| Axis Midcap Fund | 634,381 | 0.28 | 88.08 | 2,909,916 | 2025-12-08 07:12:11 | -78.2% |
| Mahindra Manulife Mid Cap Fund | 606,326 | 1.96 | 84.19 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 19.50 | 20.33 | 17.00 | 24.08 | 20.13 |
| Diluted EPS (Rs.) | 19.50 | 20.33 | 17.00 | 24.08 | 20.13 |
| Cash EPS (Rs.) | 28.34 | 27.63 | 24.24 | 30.81 | 26.45 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 134.42 | 121.46 | 109.95 | 117.57 | 95.31 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 134.46 | 121.51 | 110.00 | 117.63 | 95.37 |
| Revenue From Operations / Share (Rs.) | 216.82 | 209.72 | 191.77 | 218.61 | 158.02 |
| PBDIT / Share (Rs.) | 36.70 | 35.70 | 31.10 | 39.31 | 33.31 |
| PBIT / Share (Rs.) | 27.65 | 28.36 | 24.48 | 33.00 | 27.52 |
| PBT / Share (Rs.) | 26.12 | 27.27 | 22.93 | 32.36 | 26.87 |
| Net Profit / Share (Rs.) | 19.29 | 20.29 | 17.62 | 24.49 | 20.66 |
| NP After MI And SOA / Share (Rs.) | 19.47 | 20.30 | 16.97 | 24.07 | 20.12 |
| PBDIT Margin (%) | 16.92 | 17.02 | 16.21 | 17.98 | 21.08 |
| PBIT Margin (%) | 12.75 | 13.52 | 12.76 | 15.09 | 17.41 |
| PBT Margin (%) | 12.04 | 13.00 | 11.95 | 14.80 | 17.00 |
| Net Profit Margin (%) | 8.89 | 9.67 | 9.18 | 11.20 | 13.07 |
| NP After MI And SOA Margin (%) | 8.98 | 9.68 | 8.85 | 11.01 | 12.73 |
| Return on Networth / Equity (%) | 14.48 | 17.13 | 16.84 | 20.71 | 21.34 |
| Return on Capital Employeed (%) | 19.00 | 22.59 | 21.66 | 27.11 | 27.87 |
| Return On Assets (%) | 10.35 | 12.14 | 10.44 | 14.28 | 15.13 |
| Long Term Debt / Equity (X) | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
| Total Debt / Equity (X) | 0.03 | 0.03 | 0.02 | 0.03 | 0.02 |
| Asset Turnover Ratio (%) | 1.22 | 1.27 | 1.32 | 1.27 | 1.10 |
| Current Ratio (X) | 1.88 | 1.77 | 1.69 | 1.85 | 1.84 |
| Quick Ratio (X) | 0.99 | 0.95 | 1.03 | 1.08 | 1.16 |
| Inventory Turnover Ratio (X) | 6.06 | 3.89 | 3.99 | 4.59 | 3.23 |
| Dividend Payout Ratio (NP) (%) | 19.22 | 18.43 | 13.20 | 9.34 | 3.73 |
| Dividend Payout Ratio (CP) (%) | 13.12 | 13.54 | 9.50 | 7.40 | 2.89 |
| Earning Retention Ratio (%) | 80.78 | 81.57 | 86.80 | 90.66 | 96.27 |
| Cash Earning Retention Ratio (%) | 86.88 | 86.46 | 90.50 | 92.60 | 97.11 |
| Interest Coverage Ratio (X) | 23.90 | 33.00 | 20.91 | 61.26 | 51.11 |
| Interest Coverage Ratio (Post Tax) (X) | 13.56 | 19.75 | 12.57 | 39.16 | 32.69 |
| Enterprise Value (Cr.) | 34390.31 | 53110.31 | 35606.86 | 40137.42 | 32080.57 |
| EV / Net Operating Revenue (X) | 5.90 | 9.41 | 6.90 | 9.13 | 10.10 |
| EV / EBITDA (X) | 34.84 | 55.30 | 42.56 | 50.79 | 47.91 |
| MarketCap / Net Operating Revenue (X) | 5.96 | 9.49 | 6.97 | 9.25 | 10.23 |
| Retention Ratios (%) | 80.77 | 81.56 | 86.79 | 90.65 | 96.26 |
| Price / BV (X) | 9.62 | 16.80 | 13.27 | 17.41 | 17.15 |
| Price / Net Operating Revenue (X) | 5.96 | 9.49 | 6.97 | 9.25 | 10.23 |
| EarningsYield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
After reviewing the key financial ratios for Astral Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 19.50. This value is within the healthy range. It has decreased from 20.33 (Mar 24) to 19.50, marking a decrease of 0.83.
- For Diluted EPS (Rs.), as of Mar 25, the value is 19.50. This value is within the healthy range. It has decreased from 20.33 (Mar 24) to 19.50, marking a decrease of 0.83.
- For Cash EPS (Rs.), as of Mar 25, the value is 28.34. This value is within the healthy range. It has increased from 27.63 (Mar 24) to 28.34, marking an increase of 0.71.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 134.42. It has increased from 121.46 (Mar 24) to 134.42, marking an increase of 12.96.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 134.46. It has increased from 121.51 (Mar 24) to 134.46, marking an increase of 12.95.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 216.82. It has increased from 209.72 (Mar 24) to 216.82, marking an increase of 7.10.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 36.70. This value is within the healthy range. It has increased from 35.70 (Mar 24) to 36.70, marking an increase of 1.00.
- For PBIT / Share (Rs.), as of Mar 25, the value is 27.65. This value is within the healthy range. It has decreased from 28.36 (Mar 24) to 27.65, marking a decrease of 0.71.
- For PBT / Share (Rs.), as of Mar 25, the value is 26.12. This value is within the healthy range. It has decreased from 27.27 (Mar 24) to 26.12, marking a decrease of 1.15.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 19.29. This value is within the healthy range. It has decreased from 20.29 (Mar 24) to 19.29, marking a decrease of 1.00.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 19.47. This value is within the healthy range. It has decreased from 20.30 (Mar 24) to 19.47, marking a decrease of 0.83.
- For PBDIT Margin (%), as of Mar 25, the value is 16.92. This value is within the healthy range. It has decreased from 17.02 (Mar 24) to 16.92, marking a decrease of 0.10.
- For PBIT Margin (%), as of Mar 25, the value is 12.75. This value is within the healthy range. It has decreased from 13.52 (Mar 24) to 12.75, marking a decrease of 0.77.
- For PBT Margin (%), as of Mar 25, the value is 12.04. This value is within the healthy range. It has decreased from 13.00 (Mar 24) to 12.04, marking a decrease of 0.96.
- For Net Profit Margin (%), as of Mar 25, the value is 8.89. This value is within the healthy range. It has decreased from 9.67 (Mar 24) to 8.89, marking a decrease of 0.78.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.98. This value is within the healthy range. It has decreased from 9.68 (Mar 24) to 8.98, marking a decrease of 0.70.
- For Return on Networth / Equity (%), as of Mar 25, the value is 14.48. This value is below the healthy minimum of 15. It has decreased from 17.13 (Mar 24) to 14.48, marking a decrease of 2.65.
- For Return on Capital Employeed (%), as of Mar 25, the value is 19.00. This value is within the healthy range. It has decreased from 22.59 (Mar 24) to 19.00, marking a decrease of 3.59.
- For Return On Assets (%), as of Mar 25, the value is 10.35. This value is within the healthy range. It has decreased from 12.14 (Mar 24) to 10.35, marking a decrease of 1.79.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.03. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.22. It has decreased from 1.27 (Mar 24) to 1.22, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.88. This value is within the healthy range. It has increased from 1.77 (Mar 24) to 1.88, marking an increase of 0.11.
- For Quick Ratio (X), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 1. It has increased from 0.95 (Mar 24) to 0.99, marking an increase of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.06. This value is within the healthy range. It has increased from 3.89 (Mar 24) to 6.06, marking an increase of 2.17.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 19.22. This value is below the healthy minimum of 20. It has increased from 18.43 (Mar 24) to 19.22, marking an increase of 0.79.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 13.12. This value is below the healthy minimum of 20. It has decreased from 13.54 (Mar 24) to 13.12, marking a decrease of 0.42.
- For Earning Retention Ratio (%), as of Mar 25, the value is 80.78. This value exceeds the healthy maximum of 70. It has decreased from 81.57 (Mar 24) to 80.78, marking a decrease of 0.79.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 86.88. This value exceeds the healthy maximum of 70. It has increased from 86.46 (Mar 24) to 86.88, marking an increase of 0.42.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 23.90. This value is within the healthy range. It has decreased from 33.00 (Mar 24) to 23.90, marking a decrease of 9.10.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 13.56. This value is within the healthy range. It has decreased from 19.75 (Mar 24) to 13.56, marking a decrease of 6.19.
- For Enterprise Value (Cr.), as of Mar 25, the value is 34,390.31. It has decreased from 53,110.31 (Mar 24) to 34,390.31, marking a decrease of 18,720.00.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.90. This value exceeds the healthy maximum of 3. It has decreased from 9.41 (Mar 24) to 5.90, marking a decrease of 3.51.
- For EV / EBITDA (X), as of Mar 25, the value is 34.84. This value exceeds the healthy maximum of 15. It has decreased from 55.30 (Mar 24) to 34.84, marking a decrease of 20.46.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.96. This value exceeds the healthy maximum of 3. It has decreased from 9.49 (Mar 24) to 5.96, marking a decrease of 3.53.
- For Retention Ratios (%), as of Mar 25, the value is 80.77. This value exceeds the healthy maximum of 70. It has decreased from 81.56 (Mar 24) to 80.77, marking a decrease of 0.79.
- For Price / BV (X), as of Mar 25, the value is 9.62. This value exceeds the healthy maximum of 3. It has decreased from 16.80 (Mar 24) to 9.62, marking a decrease of 7.18.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.96. This value exceeds the healthy maximum of 3. It has decreased from 9.49 (Mar 24) to 5.96, marking a decrease of 3.53.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Astral Ltd:
- Net Profit Margin: 8.89%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19% (Industry Average ROCE: 10.4%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 14.48% (Industry Average ROE: 10.62%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 13.56
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.99
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 77.6 (Industry average Stock P/E: 56.93)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.03
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.89%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plastics - Pipes & Fittings | Astral House 207/1, B/h. Rajpath Club, Ahmedabad Gujarat 380059 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sandeep P Engineer | Chairman & Managing Director |
| Mr. Hiranand Savlani | WholeTime Director & CFO |
| Mrs. Jagruti S Engineer | Whole Time Director |
| Mr. Girish B Joshi | Whole Time Director |
| Mr. Kairav Engineer | Whole Time Director |
| Mrs. Kaushal D Nakrani | Independent Director |
| Mr. Viral M Jhaveri | Independent Director |
| Mr. C K Gopal | Independent Director |
| Mr. Chetas Desai | Independent Director |
| Mr. Dhinal Shah | Independent Director |
FAQ
What is the intrinsic value of Astral Ltd?
Astral Ltd's intrinsic value (as of 03 February 2026) is ₹1320.41 which is 10.05% lower the current market price of ₹1,468.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹39,501 Cr. market cap, FY2025-2026 high/low of ₹1,595/1,232, reserves of ₹3,749 Cr, and liabilities of ₹5,198 Cr.
What is the Market Cap of Astral Ltd?
The Market Cap of Astral Ltd is 39,501 Cr..
What is the current Stock Price of Astral Ltd as on 03 February 2026?
The current stock price of Astral Ltd as on 03 February 2026 is ₹1,468.
What is the High / Low of Astral Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Astral Ltd stocks is ₹1,595/1,232.
What is the Stock P/E of Astral Ltd?
The Stock P/E of Astral Ltd is 77.6.
What is the Book Value of Astral Ltd?
The Book Value of Astral Ltd is 141.
What is the Dividend Yield of Astral Ltd?
The Dividend Yield of Astral Ltd is 0.26 %.
What is the ROCE of Astral Ltd?
The ROCE of Astral Ltd is 19.7 %.
What is the ROE of Astral Ltd?
The ROE of Astral Ltd is 14.9 %.
What is the Face Value of Astral Ltd?
The Face Value of Astral Ltd is 1.00.